Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses

Stephen McAdam, Paul Klenerman, Lynda Tussey, Sarah Rowland-Jones, David Lalloo, Rodney Phillips, Anne Edwards, Paul Giangrande, Andrew Leigh Brown, Frances Gotch, Andrew McMichael

Research output: Contribution to journalArticlepeer-review

55 Citations (Scopus)

Abstract

Cytotoxic T lymphocyte responses in HIV infection can be impaired through variation in the epitope regions of viral proteins such as gag. We report here an analysis of variant epitope peptides in three gag epitopes presented by HLA B8. Fifteen variant peptides were examined for their binding to HLA- B8; all but one bound at concentrations comparable to known epitopes. All except two of those that bound could be recognized by CTL from an HLA-B8 positive HIV-1-infected patient and were therefore immunogenic. However, in a hemophiliac patient studied in detail, there was a failure to respond to two immunogenic peptide epitopes representing virus present as provirus in the patient's peripheral blood. In one case, the patient's CTL had previously responded to the peptide; in the other case, there was a good response to a peptide of closely related sequence. Thus there was a selective failure of the CTL response to some proviral epitopes. This impaired reaction to new variants could contribute to the loss of immune control of the infection.

Original languageEnglish
Pages (from-to)2729-2736
Number of pages8
JournalJournal of Immunology
Volume155
Issue number5
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Dive into the research topics of 'Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses'. Together they form a unique fingerprint.

Cite this